Pediatrics
Showing 401-450 of 1,612 Results
-
Noelle Hanako Ebel
Clinical Associate Professor, Pediatrics - Gastroenterology
Current Research and Scholarly InterestsCurrent projects include:
-indications for combined heart-liver transplantation
-mitigating perioperative bleeding during cardiac surgery in children with Alagille syndrome
-congenital heart disease and liver transplantation
-subspecialty advocacy -
Elizabeth Egan
Associate Professor of Pediatrics (Infectious Diseases) and of Microbiology and Immunology
Current Research and Scholarly InterestsMalaria is a parasitic disease transmitted by mosquitos that is a leading cause of childhood mortality globally. Public health efforts to control malaria have historically been hampered by the rapid development of drug resistance. The goal of our research is to understand the molecular determinants of critical host-pathogen interactions in malaria, with a focus on the erythrocyte host cell. Our long-term goal is to develop novel approaches to prevent or treat malaria and improve child health.
-
Vanessa El Kamari
Instructor, Medicine - Infectious Diseases
BioVanessa El Kamari, MD, is a physician-scientist in the Division of Infectious Diseases and Geographic Medicine at Stanford University and a member of the David Relman Laboratory. Her research investigates how host–microbe interactions in the small intestine regulate mucosal immunity, barrier integrity, and systemic inflammation in autoimmune and inflammatory diseases.
Her current studies use non-invasive sampling of the small intestine in conditions such as celiac disease, multiple sclerosis, and environmental enteropathy. She applies an integrative, multi-omic approach—combining microbiology, immunology, molecular biology, and computational biology—to define spatial immune–microbial networks along the human gut.
Before joining Stanford, Dr. El Kamari’s research focused on inflammation and immune activation in chronic HIV infection, where she identified gut barrier dysfunction as a key driver of systemic inflammation and cardiometabolic complications. She also led intervention studies targeting immune activation and endothelial dysfunction in HIV, work that laid the foundation for her current efforts to apply similar mechanistic approaches to autoimmune and inflammatory disorders. -
Yasser El-Sayed, Professor
Charles B. and Ann L. Johnson Professor in the School of Medicine and Professor, by courtesy, of Pediatrics (Neonatology) and of Surgery
Current Research and Scholarly InterestsHigh Risk Obstetrics: preterm labor, preeclampsia, medical and surgical complications of pregnancy, prenatal diagnosis and therapy
-
Gregory Enns
Professor of Pediatrics (Genetics)
Current Research and Scholarly Interestsmitochondrial genomics, lysosomal disorders, tandem-mass spectrometry newborn screening, and inborn errors of metabolism presentations and natural history
-
Mgbechi Ugonna Erondu
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
Clinical Assistant Professor (By courtesy), PediatricsBioMgbechi Ugonna Erondu, MD MFA is currently a Clinical Assistant Professor for the Department of Anesthesia, Pain and Perioperative Medicine and the Division of Quality of Life and Pediatric Palliative Care at Stanford University and is board-certified in Pediatric Anesthesiology and Hospice and Palliative Medicine. Her academic interests include the intersection between fiction writing and medical humanities, perioperative management of pediatric palliative care patients, interdisciplinary care of persons living with sickle cell disease, and equitable and inclusive global health practices.
-
Carlos O. Esquivel, M.D., Ph.D.,FACS
Arnold and Barbara Silverman Professor in Pediatric Transplantation and Professor of Surgery (Abdominal Transplantation) and of Pediatrics (Gastroenterology, Hepatology and Nutrition)
Current Research and Scholarly Interests1) Induction of immunotolerance
2) Rejection of liver and intestinal transplantation.
3) Clinical outcomes of children with unresectable liver tumors. -
Susan Payne Etheridge
Adjunct Clinical Professor, Pediatrics - Cardiology
BioDr. Etheridge is a board-certified pediatric cardiologist and electrophysiologist. Since beginning her tenure in Pediatric Cardiology, her research focus has centered on Long QT Syndrome (LQTS) and other genetic disorders leading to sudden death in the young. She directed local and multi-center collaborative projects concerning LQTS, supraventricular tachycardia and Wolff-Parkinson-White Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia and hypertrophic cardiomyopathy. She has actively participated in multicenter projects of genetic conditions associated with sudden death in the young, including Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT), Timothy Syndrome, Andersen-Tawil Syndrome, hypertrophic cardiomyopathy, sudden death in athletes, and fetal LQTS. She was the local PI for multicenter projects on hypertrophic cardiomyopathy, fetal and nonfetal LQTS, Wolff-Parkinson-White Syndrome, Timothy Syndrome and CPVT. She is an an invited speaker at local, national, and international meetings where she speaks largely on the genetic susceptibility to sudden death in the young and WPW. She has published book chapters and invited editorials and articles related to heritable sudden death conditions and sports participation and arrhythmias in congential heart disease.
Her experience as a pediatric electrophysiologist, a Fellow in the Heart Rhythm Society, past present of the Pediatric and Congenital Arrhythmia Society, member of the America College of Cardiology Electrophysiology Committee and Vice President of the Sudden Arrhythmia Death Foundation underscores her interest in and service to children and adults with arrhythmic disease. Her years on the American Board of Pediatrics and her past leadership role within the fellowship speak to her dedication to the next generation of pediatric cardiologitsts. Dr. Etheridge created and led the University of Utah Inherited Arrhythmia clinic. This is a collaborative clinic that focuses on children and adults with familial sudden death conditions with input from genetics, adult and pediatric electrophysiology and child psychology. The goal was the pre-symptomatic assessment and sudden death prevention in patients with inherited arrhythmia conditions and care for the child and the entire family. The team followed the nationally defined protocols for this assessment and engage our research, genetics and adult electrophysiology colleagues in this assessment. She is embarking upon a similar role at Stanford University. As the Vice President of the SADS Foundation, she is intimately involved with families with these conditions. She takes part in and has developed educational seminars concerning these conditions as part of her involvement with SADS. She often faces questions concerning sports participation in children and young adults with inherited conditions that put children at risk for sudden death. She is a part of the writing group for a recently published consensus document on return to play with heart conditions from the Heart Rhythm Society, American College of Cardiology and the American Heart Association.
She has dedicated some of her clinical work to the care of adults with arrhytmias in the setting of congenital heart disease and has a clinic for this population in California, Alaska and Idaho. She is scheduled to co-chair the upcoming HRS document on arrhythmia management in adults with congenital heart disease. -
Ryann Fame, PhD
Assistant Professor of Neurosurgery (Adult Neurosurgery)
Current Research and Scholarly InterestsEarly neural progenitors respond to extrinsic cues that maintain and support their potency. These stem/ progenitor cells are in direct contact with the cerebrospinal fluid (CSF), which acts as part of their niche. Our research program encompasses the early neural stem cell niche, neural tube closure, CSF, metabolism, and cortical neuronal development. We are dedicated to broad collaboration focused on translating an understanding of neurodevelopment and CSF biology into regenerative strategies.
-
Jeffrey A. Feinstein, MD, MPH
Dunlevie Family Professor of Pulmonary Vascular Disease and Professor, by courtesy, of Bioengineering
Current Research and Scholarly InterestsResearch interests include (1) computer simulation and modeling of cardiovascular physiology with specific attention paid to congenital heart disease and its treatment, (2) the evaluation and treatment of pulmonary hypertension/pulmonary vascular diseases, and (3) development and testing of medical devices/therapies for the treatment of congenital heart disease and pulmonary vascular diseases.
-
Heidi M. Feldman
Professor of Pediatrics (Developmental-Behavioral)
Current Research and Scholarly InterestsMy current research program focuses on infants born preterm, before 32 weeks gestation from two language environments: English and Spanish. The study considers how neurobiological factors, specifically properties of the white matter circuits in the brain, interact with social, psychological, and economic factors to predict language processing efficiency at 18 months of age.
-
Philip Fernandes
Masters Student in Translational Research and Applied Medicine, admitted Autumn 2026
Fellow in Pediatrics - GastroenterologyBioI am a Clinical Fellow in Pediatric Gastroenterology, Hepatology, and Nutrition and a Tashia and John Morgridge Endowed Postdoctoral Fellow at Stanford University and Lucile Packard Children’s Hospital, supported by the Maternal & Child Health Research Institute. I completed my residency at Henry Ford St. John Hospital in Detroit, where caring for diverse communities shaped my dedication to health equity and cultural humility.
In the Rosen Lab, my research centers on pediatric ulcerative colitis (UC). I use 3D colonoids—lab-grown models of the colon derived from intestinal stem cells—alongside single-cell genomic technologies to map cellular metabolic changes and cell-to-cell interactions. By decoding these cellular dynamics, my goal is to uncover targeted, precise therapies that better control disease, prevent complications, and support long-term growth, nutrition, and overall health for pediatric patients.
This work builds on my foundation in pediatric gastroenterology at the University of Virginia’s Syed Lab, where I contributed to data interpretation, grant development, and multi-institutional research integrating genomics and machine learning to investigate gastrointestinal structure and function.
As a student in the Master's in Translational Research and Applied Medicine (M-TRAM) program, I am building actionable skills across clinical medicine, translational research, and industry-driven approaches to innovation, preparing to advance therapeutics for complex pediatric enteropathies. -
Nielsen Fernandez-Becker
Clinical Professor, Medicine - Gastroenterology & Hepatology
BioI am the director of the Celiac Disease Program at Stanford and I am highly experienced in diagnosis and management of celiac disease and gluten associated disorders.
My objective is to provide excellent and compassionate clinical care for my patients while seeking a better understanding of diseases I treat, particularly Celiac disease (CeD), eosinophilic esophagitis (EoE). My top priorities are patient care and translational research to make new discoveries and improve the care my patients. -
Caroline Figueroa, MD PhD
Visiting Scholar, Pediatrics - General Pediatrics
BioCaroline Figueroa, MD, PhD, is a visiting scholar at Stanford University. She is the 2025–26 Dutch Commonwealth Fund Harkness Fellow in Health Care Policy and Practice. She is an assistant professor at Delft University of Technology (TU Delft) in the Netherlands, where she leads the Research on Inclusive Solutions and Empowerment in Digital Health (RISE) group. Her work focuses on making digital mental health solutions — such as apps and AI-chatbots — safe, effective, and accessible, particularly for adolescents, young adults, and women. Figueroa’s research on digital health equity has directly informed policy documents by global organizations such as the World Health Organization and the United Nations, and has been published in leading journals including Lancet Digital Health, Journal of the American Medical Informatics Association, and Human Brain Mapping.
Figueroa is a medical doctor with a PhD in the neuroscience of depression from the University of Amsterdam and the University of Oxford; she also has several years of experience in clinical psychiatry. Before joining TU Delft, she was a postdoctoral scholar at the University of California, Berkeley. -
Michael Fischbach
Liu (Liao) Family Professor
Current Research and Scholarly InterestsThe microbiome carries out extraordinary feats of biology: it produces hundreds of molecules, many of which impact host physiology; modulates immune function potently and specifically; self-organizes biogeographically; and exhibits profound stability in the face of perturbations. Our lab studies the mechanisms of microbiome-host interactions. Our approach is based on two technologies we recently developed: a complex (119-member) defined gut community that serves as an analytically manageable but biologically relevant system for experimentation, and new genetic systems for common species from the microbiome. Using these systems, we investigate mechanisms at the community level and the strain level.
1) Community-level mechanisms. A typical gut microbiome consists of 200-250 bacterial species that span >6 orders of magnitude in relative abundance. As a system, these bacteria carry out extraordinary feats of metabolite consumption and production, elicit a variety of specific immune cell populations, self-organize geographically and metabolically, and exhibit profound resilience against a wide range of perturbations. Yet remarkably little is known about how the community functions as a system. We are exploring this by asking two broad questions: How do groups of organisms work together to influence immune function? What are the mechanisms that govern metabolism and ecology at the 100+ strain scale? Our goal is to learn rules that will enable us to design communities that solve specific therapeutic problems.
2) Strain-level mechanisms. Even though gut and skin colonists live in communities, individual strains can have an extraordinary impact on host biology. We focus on two broad (and partially overlapping) categories:
Immune modulation: Can we redirect colonist-specific T cells against an antigen of interest by expressing it on the surface of a bacterium? How do skin colonists induce high levels of Staphylococcus-specific antibodies in mice and humans?
Abundant microbiome-derived molecules: By constructing single-strain/single-gene knockouts in a complex defined community, we will ask: What are the effects of bacterially produced molecules on host metabolism and immunology? Can the molecular output of low-abundance organisms impact host physiology?
3) Cell and gene therapy. We have begun two new efforts in mammalian cell and gene therapies. First, we are developing methods that enable cell-type specific delivery of genome editing payloads in vivo. We are especially interested in delivery vehicles that are customizable and easy to manufacture. Second, we have begun a comprehensive genome mining effort with an emphasis on understudied or entirely novel enzyme systems with utility in mammalian genome editing. -
Paul Graham Fisher, MD
Beirne Family Professor of Pediatric Neuro-Oncology, Professor of Pediatrics and, by courtesy, of Neurosurgery and of Epidemiology and Population Health
Current Research and Scholarly InterestsClinical neuro-oncology: My research explores the epidemiology, natural history, and disease patterns of brain tumors and other cancers in childhood, as well as prospective clinical trials for treating these neoplasms. Research interests also include neurologic effects of cancer and its therapies.
-
Philip Andrew Fisher
Diana Chen Professor of Early Childhood Learning and Professor, by courtesy, of Pediatrics
BioDr. Philip Fisher is the Diana Chen Professor of Early Childhood Learning in the Graduate School of Education and the Director of the Stanford Center on Early Childhood. His research, focuses on developing and evaluating scalable early childhood interventions in communities, and on translating scientific knowledge regarding healthy development under conditions of adversity for use in social policy and programs. He is particularly interested in the effects of early stressful experiences on children's development, and in prevention and treatment programs for improving children's functioning in areas such as relationships with caregivers and peers, social-emotional development, and academic achievement. He is currently the lead investigator in the ongoing RAPID-EC project, a national survey on the well-being of households with young children during the COVID-19 pandemic. Dr. Fisher is the developer of a number of widely implemented evidence-based interventions for supporting healthy child development in the context of social and economic adversity, including Treatment Foster Care Oregon for Preschoolers (TFCO-P) and Kids in Transition to School (KITS). Most recently, he developed the Filming Interactions to Nurture Development (FIND) video coaching program for supporting parenting in the home environment and early childhood care and education professionals in childcare and preschool contexts. He has published over 250 scientific papers in peer reviewed journals. He is the recipient of the 2012 Society for Prevention Research Translational Science Award, and a 2019 Fellow of the American Psychological Society.
-
Barry Fleisher
Associate Professor of Pediatrics at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsNeonatology, neurobehavioral development, outcomes in premature infants.
